Oppenheimer Holdings Stock News

Oatly Group AB (NASDAQ:OTLY) Research analysts at Oppenheimer lowered their Q4 2021 EPS estimates for shares of Oatly Group in a report released on Tuesday, November 16th. Oppenheimer analyst R. Parikh now forecasts that the company will post earnings per share of ($0.12) for the quarter, down from their previous estimate of ($0.10). Oppenheimer []

Analog Devices (NASDAQ:ADI) had its price objective hoisted by analysts at Oppenheimer from $200.00 to $210.00 in a report released on Friday, The Fly reports. The firm currently has an outperform rating on the semiconductor companys stock. Oppenheimers price objective points to a potential upside of 11.23% from the companys previous close. Several other research []

Denali Advisors LLC grew its holdings in shares of Oppenheimer Holdings Inc. (NYSE:OPY) by 19.1% during the third quarter, Holdings Channel.com reports. The institutional investor owned 5,600 shares of the financial services providers stock after purchasing an additional 900 shares during the quarter. Denali Advisors LLCs holdings in Oppenheimer were worth $254,000 at the end []

Aramark (NYSE:ARMK) Equities researchers at Oppenheimer issued their Q1 2022 earnings per share estimates for shares of Aramark in a research note issued to investors on Tuesday, November 16th. Oppenheimer analyst I. Zaffino expects that the company will post earnings of $0.19 per share for the quarter. Oppenheimer also issued estimates for Aramarks Q2 []

Oatly Group AB (NASDAQ:OTLY) Equities researchers at Oppenheimer cut their Q4 2021 earnings estimates for Oatly Group in a report issued on Tuesday, November 16th. Oppenheimer analyst R. Parikh now forecasts that the company will earn ($0.12) per share for the quarter, down from their previous estimate of ($0.10). Oppenheimer also issued estimates for []

Eagle Point Credit Company Inc. (NYSE:ECC) Analysts at Oppenheimer raised their FY2021 EPS estimates for shares of Eagle Point Credit in a research report issued to clients and investors on Tuesday, November 16th. Oppenheimer analyst M. Penn now forecasts that the investment management company will post earnings of $1.29 per share for the year, []

Several analysts have recently updated their ratings and price targets for Under Armour (NYSE: UAA): 11/3/2021 Under Armour had its price target raised by analysts at Oppenheimer Holdings Inc. from $30.00 to $34.00. They now have an outperform rating on the stock. 11/3/2021 Under Armour was upgraded by analysts at Telsey Advisory Group []

MediWound Ltd. (NASDAQ:MDWD) Equities research analysts at Oppenheimer cut their FY2021 earnings per share (EPS) estimates for MediWound in a research note issued on Tuesday, November 16th. Oppenheimer analyst K. Degeeter now expects that the biopharmaceutical company will earn ($0.48) per share for the year, down from their previous estimate of ($0.46). Oppenheimer also []

Regal Rexnord (NYSE:RRX) had its target price raised by equities research analysts at KeyCorp from $185.00 to $200.00 in a report released on Friday, Stock Target Advisor reports. The firm presently has an “overweight” rating on the stock. KeyCorp’s price target would suggest a potential upside of 16.83% from the company’s previous close. Separately, Oppenheimer […]

Oppenheimer (NYSE: OPY) is one of 53 public companies in the Security brokers & dealers industry, but how does it weigh in compared to its peers? We will compare Oppenheimer to similar companies based on the strength of its analyst recommendations, risk, earnings, profitability, dividends, valuation and institutional ownership. Valuation and Earnings This table compares []

127619 (MDN.TO) (TSE:MDN) Analysts at Oppenheimer cut their Q3 2022 EPS estimates for shares of 127619 (MDN.TO) in a research report issued on Monday, November 15th. Oppenheimer analyst M. Biegler now forecasts that the mining company will post earnings per share of ($0.14) for the quarter, down from their previous forecast of ($0.12). Oppenheimer []

CYBIN INC. (CYBN.NE) (OTCMKTS:CYBN) Oppenheimer lowered their Q3 2022 earnings per share (EPS) estimates for CYBIN INC. (CYBN.NE) in a research report issued on Tuesday, November 16th. Oppenheimer analyst F. Brisebois now expects that the company will earn ($0.09) per share for the quarter, down from their previous forecast of ($0.07). Oppenheimer currently has []

Rezolute, Inc. (NASDAQ:RZLT) Equities researchers at Oppenheimer lifted their Q2 2022 EPS estimates for Rezolute in a report released on Monday, November 15th. Oppenheimer analyst K. Degeeter now anticipates that the company will post earnings of ($0.66) per share for the quarter, up from their prior estimate of ($0.91). Oppenheimer also issued estimates for []

Angion Biomedica Corp. (NASDAQ:ANGN) Equities researchers at Oppenheimer raised their FY2021 earnings per share (EPS) estimates for Angion Biomedica in a report released on Monday, November 15th. Oppenheimer analyst J. Kim now forecasts that the company will post earnings of ($3.20) per share for the year, up from their prior forecast of ($3.52). Oppenheimer []

89bio, Inc. (NASDAQ:ETNB) Stock analysts at Oppenheimer dropped their FY2021 EPS estimates for shares of 89bio in a research note issued on Monday, November 15th. Oppenheimer analyst J. Olson now forecasts that the company will post earnings per share of ($4.71) for the year, down from their prior estimate of ($4.05). Oppenheimer also issued []